Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer

E-ISSN： 1346-8138|42|12|1198-1199

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.42, Iss.12, 2015-12, pp. : 1198-1199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delayed Paclitaxel-Trastuzumab-Induced Interstitial Pneumonitis in Breast Cancer

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-04 ,pp. : 186-191

Karger

Access to resources Recommend Favorite

Paclitaxel in breast cancer

By Patt Debra Gauthier Michelle Giordano Sharon

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 11-21

Future Medicine

Access to resources Recommend Favorite

Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 687-692

Karger

Access to resources Recommend Favorite

Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-07 ,pp. : 605-612

Karger

Access to resources Recommend Favorite

Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-04 ,pp. : 252-259

Karger

Access to resources Recommend Favorite